Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
AzurRz BioPharma Acquires First Wave Bio
AzurRz BioPharma, Inc., a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced that it has entered into a definitive agreement to acquire First Wave Bio, Inc. in a stock and cash transaction valued at $229 million. H.C. Wainwright & Co. acted as advisor to AzurRx in connection with the acquisition. Founded in 2015, First Wave Bio, Inc. is a clinical-stage biotechnology company specializing in the development of novel, gut-targeted, small molecule therapies for the treatment of auto-immune inflammatory bowel diseases (IBD) and other serious conditions. AzurRx also announced that it... Read More »
The Transcript: Q2 Highlights From Healthcare CEOs
What better way to get an understanding of the healthcare market than through the CEOs of the top companies themselves? Leaders across different segments, including hospitals, telehealth, managed care, home health and more, reported strong growth and activity and have a confident outlook for the rest of the year. Health System Rebound “…we are delivering a much stronger growth trajectory on the hospital side in terms of admissions, outpatient visits, ER volumes, and surgeries. In particular, the higher acuity work that we have been focused on with general surgery, cardiovascular, ortho, neuro, etc., have been steadily progressing in key markets across the country.” – Tenet Healthcare Corp.... Read More »
A Conversation With M&A Healthcare Advisors, a Newly Launched Boutique Advisory Firm Focused on Healthcare M&A
The healthcare editorial team at Irving Levin Associates sat down with industry veterans Mike Moran and Andre Ulloa to discuss the launch of their new advisory firm, M&A Healthcare Advisors (MAHA), and the state of the healthcare M&A market. MAHA aims to transform the M&A experience for lower-middle market healthcare business owners by providing highly accessible, transparent and experience-driven seller-representation services throughout the entire sale process. What motivated you to launch the new firm?Andre: We saw a huge void when it came to lower-middle market seller representation in the healthcare industry. These smaller healthcare agencies are often... Read More »
Definitive Healthcare Launches Into the Public Sphere
Definitive Healthcare, the leading provider of healthcare intelligence for go-to-market sales strategies, announced the terms for its IPO last week, with plans to list on the Nasdaq under the symbol DH. The Framingham, MA-based company plans to raise $350 million by offering 15.6 million shares at a price range of between $21 to $24. New investors BlackRock and Capital World plan to purchase $80 million worth of shares, or 23% of the deal, in the offering. At a midpoint of the proposed range, Definitive Healthcare would command a market value of $3.3 billion. Founded in 2011, Definitive Healthcare provides healthcare commercial intelligence to its over 2,600 customers (as of June 30,... Read More »
NorthShore University HealthSystem & Edward-Elmhurst Health Merge
Two Illinois-based health systems have announced they are merging. Edward-Elmhurst Health, a not-for-profit health system, is joining NorthShore University HealthSystem, another not-for-profit system located in the Chicago market. Edward-Elmhurst Health is a 736-bed system that includes two hospitals and one behavioral health hospital and has more than 60 outpatient locations across Chicago’s west and southwest suburbs. The hospitals are Edward Hospital, Elmhurst Hospital and Linden Oaks Behavioral Health. Edward-Elmhurst generated $1.14 billion in revenue in 2020 and $62.27 million in EBITDA. NorthShore, for its part, generates around $1.5 billion in annual revenues, according to the... Read More »
Health Care M&A Deals, September 3, 2021
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our new LevinPro Healthcare and LTC platform, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. To subscribe to our Health Care M&A deals chart and more, visit our membership site. LevinPro is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets. Biotechnology AcquirerTargetPriceVectivBio... Read More »
WELL Health Technologies Corp. Acquires wisp
The digital health provider WELL Health Technologies Corp. has announced a new deal for Silicon Valley-based wisp, Inc. (WISP). WELL Health is a prolific strategic buyer in the healthcare M&A market (20 deals over three years) and has a robust network of clinics and telehealth operations in British Columbia, but has been making moves in the United States recently. The deal for WISP is valued at approximately $41 million, comprised of $27.7 million in cash and $6.2 million in WELL Health shares. WELL Health is acquiring roughly 53% of WISP, and the transaction includes a multi-year performance earnout up to a maximum of $7.4 million. WISP is a leading national provider of telehealth... Read More »
Charter Health Care Group Expands in Texas
The private equity-backed Charter Health Care Group has struck a deal for two home health agencies in the Texas market. Charter Health is acquiring Genesis HospiceCare and Saints Hospice for an undisclosed sum. Founded in 1995, Genesis HospiceCare has provided high-quality hospice care to patients and families in the Athens, Texas, community for more than 25 years while Saints Hospice has served the Plano community for 15 years. No terms were disclosed. Charter offers a broad spectrum of post-acute care services for patients navigating the last years of life, including hospice, palliative care, acute/hospital-based care, skilled home health and private duty home care. Charter’s... Read More »
Confluent Health Strikes Fourth Deal in 2021
With the backing of Partners Group, the physical and occupational therapy firm Confluent Health just announced its fourth deal of the year, acquiring Manual Edge Physical Therapy for an undisclosed sum. Manual Edge Physical Therapy is a private and therapist-owned physical therapy practice. It offers a diverse list of services including treatments for back and neck pain, extremity pain, concussion, headache, TMJ, and other facial pain as well as specialties specific to women’s and men’s health. The practice is based in Colorado Springs, Colorado. This partnership allows for Manual Edge PT to maintain its existing brand while gaining access to Confluent Health’s shared management services.... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
